May 14, 2019
2,829
34
5
1.38%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:55Now PlayingBayer AG was ordered to pay more than $2 billion in damages to a California couple that claimed they got cancer as a result of using its Roundup weedkiller for about three decades, raising pressure on the company to settle thousands of similar lawsuits.
It’s the largest jury award in the U.S. so far this year and the eighth-largest ever in a product-defect claim, according to data compiled by Bloomberg. The verdict prompted some analysts to boost their estimates on the value of a settlement.
Bayer’s third Roundup court loss comes two weeks after shareholders disavowed Chief Executive Officer Werner Baumann at a meeting in Germany, lambasting his handling of the $63 billion Monsanto Co. acquisition. The verdict puts the onus on Bayer to alter its defense course and consider a settlement: litigation concerns have eroded Bayer’s value by more than 40 percent since the deal was sealed in June.
The stock declined 2.3% Tuesday after initially dropping to a seven-year low. Analysts at Bloomberg Intelligence raised their estimate for a settlement value to as much as $10 billion, up from a peak of $6 billion.
“The company has got to come to the table with a viable plan to resolve these cases, or the losses are going to mount,” Micah Dortch, managing partner at the Potts Law Firm in Dallas who has filed dozens of Roundup cases, said by email. “This outcome should make Monsanto realize the seriousness of these claims and how a jury perceives the evidence.”
Bayer CEO Werner Baumann Faces Shareholders at AGM
Werner BaumannPhotographer: Jasper Juinen/Bloomberg
Bayer vowed to challenge Monday’s ruling, calling it “excessive and unjustifiable.” Bayer has defended the safety of Roundup’s active ingredient glyphosate since inheriting the product from Monsanto.
Bayer AG was ordered to pay more than $2 billion in damages to a California couple that claimed they got cancer as a result of using its Roundup weedkiller for about three decades, raising pressure on the company to settle thousands of similar lawsuits.
It’s the largest jury award in the U.S. so far this year and the eighth-largest ever in a product-defect claim, according to data compiled by Bloomberg. The verdict prompted some analysts to boost their estimates on the value of a settlement.
Bayer’s third Roundup court loss comes two weeks after shareholders disavowed Chief Executive Officer Werner Baumann at a meeting in Germany, lambasting his handling of the $63 billion Monsanto Co. acquisition. The verdict puts the onus on Bayer to alter its defense course and consider a settlement: litigation concerns have eroded Bayer’s value by more than 40 percent since the deal was sealed in June.
The stock declined 2.3% Tuesday after initially dropping to a seven-year low. Analysts at Bloomberg Intelligence raised their estimate for a settlement value to as much as $10 billion, up from a peak of $6 billion.
“The company has got to come to the table with a viable plan to resolve these cases, or the losses are going to mount,” Micah Dortch, managing partner at the Potts Law Firm in Dallas who has filed dozens of Roundup cases, said by email. “This outcome should make Monsanto realize the seriousness of these claims and how a jury perceives the evidence.”
Bayer CEO Werner Baumann Faces Shareholders at AGM
Werner BaumannPhotographer: Jasper Juinen/Bloomberg
Bayer vowed to challenge Monday’s ruling, calling it “excessive and unjustifiable.” Bayer has defended the safety of Roundup’s active ingredient glyphosate since inheriting the product from Monsanto.
Subscribe to our YouTube channel
TICTOC ON SOCIAL:
Follow TicToc on Twitter
Like TicToc on Facebook
Follow TicToc on Instagram
Watch all of TicToc’s videos
Listen to TicToc’s podcast
Subscribe to our newsletter
TicToc by Bloomberg is global news for the life you lead. We are a 24/7 news network that covers breaking news, politics, technology, business and entertainment stories from around the globe, supported by a network of Bloomberg’s 2,700 journalists across 120 countries.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.